Allegheny General Hospital, Pittsburgh
Research in oncology provides new insights
Published in Surgery Litigation and Law Weekly, December 16th, 2005
Study 1: Endoglin and vascular endothelial growth factor (VEGF) mark esophageal adenocarcinoma angiogenesis.
According to recent research from the United States, "endoglin (CD105), a member of transforming growth factor beta 1 receptor complex, has been shown to be a more useful marker to identify tumor angiogenesis than panendothelial markers such as CD31. We investigated endoglin and VEGF expression as possible prognostic markers in esophageal adenocarcinoma."
"Surgical specimens from 75 patients with esophageal adenocarcinoma treated with...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Surgery Litigation and Law Weekly
More Articles from Surgery Litigation and Law Weekly
- Good Samaritan Hospital, Cincinnati
Age appears to influence the risk of death and disease for octogenarians after heart surgery - Kuros Biosurgery AG
Baxter gains rights to commercialize hard and soft tissue-repair products - M.D. Anderson Cancer Center
2-cyano-3,12-dioxooleana-1,9-dien-28-imidazolide (CDDO-Im) induced apoptosis in pancreatic cancer - NovaMed, Inc.
Ambulatory surgery operator acquires Nebraska surgicenter - A Gemelli University Hospital, Rome
MRI provides better performance in endometrial carcinoma than other modalities - Azienda Ospedaliera Universitaria, Parma
Researchers' data advance cancer therapy research - More from this issue of Surgery Litigation and Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
